Postthrombotic Syndrome

Known as: Venous Stasis Syndrome, Postthrombotic Syndrome [Disease/Finding], Syndrome, Venous Stasis 
A condition caused by one or more episodes of DEEP VEIN THROMBOSIS, usually the blood clots are lodged in the legs. Clinical features include EDEMA… (More)
National Institutes of Health

Related topics

Related topics

15 relations
Cardiovascular DiseasesIn BloodMicrobiologicalPostphlebitic Syndrome
(More)

Broader (2)

Vascular Diseasescirculatory disorders

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
BACKGROUND This article addresses the treatment of VTE disease. METHODS We generated strong (Grade 1) and weak (Grade 2… (More)
  • figure 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Review
2009
Review
2009
How I treat postthrombotic syndrome.
Postthrombotic syndrome (PTS) is a chronic complication of deep venous thrombosis (DVT) that reduces quality of life and has… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
This chapter about treatment for venous thromboembolic disease is part of the American College of Chest Physicians Evidence-Based… (More)
  • table 1
  • table 1
  • table 2
  • table 11
  • table 12
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome.
BACKGROUND About 30% of patients with an episode of adequately treated deep venous thrombosis (DVT) develop the postthrombotic… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939--an oral, direct Factor Xa inhibitor.
BAY 59-7939 is an oral, direct Factor Xa (FXa) inhibitor in development for the prevention and treatment of arterial and venous… (More)
Is this relevant?
Review
2004
Review
2004
Relationship between deep venous thrombosis and the postthrombotic syndrome.
The postthrombotic syndrome (PTS) is a frequent complication of deep venous thrombosis (DVT). Clinically, PTS is characterized by… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Review
2004
Review
2004
Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
This chapter about antithrombotic therapy for venous thromboembolic disease is part of the seventh ACCP Conference on… (More)
  • table 1
  • table 1
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Progranulin is a mediator of the wound response
Annually, 1.25 million individuals suffer burns in the United States and 6.5 million experience chronic skin ulcers, often from… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Review
2001
Review
2001
Natural history of venous thromboembolism.
Most deep vein thromboses (DVTs) start in the calf; however, thrombi that remain confined to the calf rarely cause leg symptoms… (More)
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: a one- to six-year follow-up.
PURPOSE This study investigated changes in the deep venous system and the development of the postthrombotic syndrome (PTS) after… (More)
Is this relevant?